A new international charter is calling for people with diabetes to have far greater control over the health data generated by the devices they rely on daily. The Diabetes Data Rights Charter, developed through an 18-month collaboration involving patients, clinicians, researchers, and advocates, responds to a growing concern at the heart of digital healthcare: who owns the data produced by smart medical devices?

Continuous glucose monitors (CGMs), insulin pumps, and automated insulin delivery systems generate vast amounts of highly personal health data. According to the University of Birmingham, which led the project alongside University College Dublin, people with diabetes currently have limited access to their own data or control over how it is collected, shared, and used.

Project co-leader Muireann Quigley, Professor of Law, Medicine, and Technology at the University of Birmingham, said in a statement: "Across the world, people with diabetes have had their quality of life improved by smart medical devices, such as continuous glucose monitors and automated insulin pumps, to help them manage their diabetes. However, as with most kinds of modern technology, questions around access to and control of the data gathered by these devices and their manufacturers remain fraught."

Quigley added: "Users of these devices often don't have full access to their own data, or don't know how it is being used by the medical device companies. This Charter aims to establish a new benchmark for best practice across the diabetes technology sector, allowing people with diabetes to have better transparency and control when it comes to their data."

The charter is built around five core principles with accompanying rights: Data Access (real-time, secure access in a usable format); Privacy and Security (private and secure storage and transfer); Benefits and Interests (the needs of those most affected come first); Choice and Control (meaningful consent over data sharing); and Accountability and Transparency (clear disclosure of how data is collected, stored, and used).

The charter also raises concerns about what it describes as "bundled" or "coerced" consent, where users must agree to extensive data-sharing arrangements to access key device functions. Lengthy terms and conditions can limit understanding of how data will be used, the authors argue.

The University of Birmingham noted that Dexcom, one of the world's leading CGM manufacturers, faced lawsuits and public outcry when it pushed an in-app notification requiring users to accept updated terms or discontinue use of the app. This kind of situation is typical for internet-connected gadgets, where using essential features requires accepting privacy terms that mandate ongoing data transmission to the device maker. When users revoke permission, important functions may cease to operate, offering them no real choice.

Dr Shane O'Donnell, a Research Fellow at University College Dublin and co-lead on the charter project, lives with diabetes. He said: "What episodes like Dexcom reveal is that people care intimately about the data they rely on to make life-or-death decisions every single day. The Diabetes Data Rights Charter helps the community articulate those concerns – and challenges the wider healthcare system to adopt data practices that more adequately meet their needs."

Tim Street, who lives with type 1 diabetes and covers diabetes technology on his blog Diabettech, said: "Until about 10 years ago, my records were mine: pen, paper, and whatever I chose to write down. CGMs and apps have dramatically improved my life with type 1 diabetes, but I've lost the ability to look back at the granular data. Access to my data in the format I want, not only how a manufacturer decides I should get it, is one of the many reasons why this Charter is important to me. I have rights over the health data generated by my body."

The University of Birmingham stated that the charter's fundamental principles are compatible with existing data governance frameworks, including the EU and UK General Data Protection Regulation and the US Health Insurance Portability and Accountability Act. However, the charter goes beyond existing legal rights to articulate standards of best practice for those interacting with and entrusted with the care of this data.

For university students studying medicine, law, public health, or data ethics, the charter raises questions about how emerging technologies balance innovation with patient rights. It also highlights a growing area of advocacy and regulation that could shape future careers in health technology and policy.